Omicron neutralisation: RBD-dimer booster versus BE.7 and BA.5.2 breakthrough infection., Not mentioned, 2023
A booster of Delta-Omicron RBD-dimer protein subunit vaccine augments sera neutralization of Omicron sub-variants BA.1/BA.2/BA.2.12.1/BA.4/BA.5, Not mentioned, 2023
Inside-out assembly of viral antigens for the enhanced vaccination, Not mentioned, 2023
Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine, Not mentioned, 2023
Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2, Not mentioned, 2022
Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults, Not mentioned, 2022
Omicron SARS-CoV-2 Neutralization from Inactivated and ZF2001 Vaccines, Not mentioned, 2022
Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults, Not mentioned, 2022
新药导读：新冠病毒蛋白亚单位疫苗, Not mentioned, 2022
mRNA vaccines expressing homo-prototype/Omicron anchetero-chimeric RBD-dimers against SARS-CoV-2, Not mentioned, 2022
Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch, Not mentioned, 2021
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials, Not mentioned, 2021
Avian influenza A(H7N9) virus: from low pathogenic to highly pathogenic, Not mentioned, 2021
Neutralisation of ZF2001-elicited antisera to SARS-CoV-2 variants, Not mentioned, 2021
Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19, Not mentioned, 2021
Heterologous prime-boost immunizations with chimpanzee adenoviral vectors elicit potent and protective immunity against SARS-CoV-2 infection, Not mentioned, 2021
Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch, Not mentioned, 2021
Serum sample neutralisation of BBIBP-CorV and ZF2001 vaccines to SARS-CoV-2 501Y.V2, Not mentioned, 2021
Viral targets for vaccines against COVID-19, Not mentioned, 2021
Humoral and cellular immunity and the safety of COVID-19 vaccines: a summary of data published by 21 May 2021, Not mentioned, 2021
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials, Not mentioned, 2021
A universal design of betacoronavirus vaccines against COVID-19, MERS, and SARS, Not mentioned, 2020
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS, Not mentioned, 2020
A universal design of betacoronavirus vaccines against COVID-19, MERS and SARS, Not mentioned, 2020
Molecular Basis of a Protective/Neutralizing Monoclonal Antibody Targeting Envelope Proteins of both Tick-Borne Encephalitis Virus and Louping Ill Virus, Not mentioned, 2019
Human Neonatal Fc Receptor Is the Cellular Uncoating Receptor for Enterovirus B, Not mentioned, 2019
Double Lock of a Human Neutralizing and Protective Monoclonal Antibody Targeting the Yellow Fever Virus Envelope, Not mentioned, 2019
Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage, Not mentioned, 2018
Molecular Basis of Antibody-Mediated Neutralization and Protection Against Flavivirus, Not mentioned, 2016
Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody, Not mentioned, 2016
Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus, Not mentioned, 2016
Modified Vaccinia Virus Ankara Triggers Type I IFN Production in Murine Conventional Dendritic Cells via a cGAS/STING-Mediated Cytosolic DNA-Sensing Pathway, Not mentioned, 2014
Diverse Peptide Presentation of Rhesus Macaque Major Histocompatibility Complex Class I Mamu-A*02 Revealed by Two Peptide Complex Structures and Insights into Immune Escape of Simian Immunodeficiency Virus, Not mentioned, 2011
恒河猴MHC-I类分子Mamu-A*02与猴免疫缺陷病毒抗原表位复合物的纯化和晶体学分析, Not mentioned, 2009
三种食品致突能力的研究, Not mentioned, 2005
Neutralisation of ZF2001-elicited antisera to SARS-CoV-2 variants, Not mentioned
Area of Focus
Tumor | Immunotherapy | Translational Research | Cancer | Therapy | Immune Response | Clinical Trials | Biomedical Research | Oncology | Medical Science
